drugset / Trial / NCT06055244
Amantadine Therapy for Cognitive Impairment in Long COVID
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will look at the effects of amantadine on cognitive function in persons with Long COVID. It will also collect specimens to study possible causes of cognitive symptoms in Long COVID, and whether any lab tests can predict who will respond better to amantadine.
Timeline
- Start
- 2023-12-07
- Primary completion
- 2025-12-11
- Completion
- 2025-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amantadine | Unknown | 100 mg | — |